Evidence map›Paper›PMID 41886659›Full record

ArticleRhode Island medical journal (2013)2026

Addressing Chronic Steatotic Liver Disease through Community Partnerships, Integrated Behavioral Interventions, and Point-of-Care Diagnostics.

Hayley Treloar Padovano, Mollie A Monnig, Ardhys De Leon, Kittichai Promrat, Maria De Sousa, Julissa Godin, Jacob Talamantes, Abigaíl Morales, Kevin McCurdy, Wendy Hernandez and 3 more

Abstract read
PubMed Full text at PMC
In one paragraph

Article in Rhode Island medical journal (2013), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hayley Treloar PadovanoCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Mollie A MonnigCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Ardhys De LeonCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Kittichai PromratProvidence VA Medical Center and Brown University Health, Providence, RI.
Maria De SousaClínica Esperanza/Hope Clinic, Providence, RI.
Julissa GodinCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Jacob TalamantesCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Abigaíl MoralesCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Kevin McCurdyCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Wendy HernandezCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Stephanie GoldsteinThe Miriam Hospital Weight Control & Diabetes Research Center, Warren Alpert Medical School of Brown University, Providence, RI.
Peter M MontiCenter for Alcohol and Addiction Studies, Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI.
Morgan LeonardClínica Esperanza/Hope Clinic, Providence, RI.

Funding

Using wearables and EMA to examine the links between cannabis and depressionP20GM130414 · NIGMS · BROWN UNIVERSITY · PI Cara Murphy · 2019 to 2026
$22.0M
NIGMS NIH HHS P20 GM130414
6 · The paper itself

Abstract

objectiveTo evaluate the feasibility of a community- based, point-of-care (POC) screening and intervention model for Metabolic and Alcohol-associated Liver Disease (MetALD) in an underserved Rhode Island population. APPROACH: A partnership between the Brown University CADRE and Clínica Esperanza/Hope Clinic (CEHC) utilized electronic health record (EHR) screening followed by on-site FibroScan® imaging and a Motivational Interviewing (MI) lifestyle intervention.

resultsPreliminary pilot data identified liver stiffness (fibrosis) in 21% of participants and steatosis in 57%. All identified patients were previously unaware of their condition.

conclusionsIntegrating POC diagnostics with culturally attuned behavioral interventions in a community- centric clinic can bypass traditional barriers to care and detect "silent" liver disease at treatable stages.

Indexed as

Fatty LiverPoint-of-Care SystemsAdultAgedChronic DiseaseCommunity-Based Participatory ResearchElasticity Imaging TechniquesFeasibility StudiesFemaleHumansMaleMass ScreeningMiddle AgedPilot ProjectsRhode Islandcommunity-based participatory researchFibroScan®metabolic and alcohol-associated liver diseaseMetALDsteatotic liver diseaseVCTE™vibration-controlled transient elastography

Identifiers

PMID41886659
PMCPMC13224085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.